Chemoradiotherapy of locally-advanced non-small cell lung cancer: Analysis of radiation dose–response, chemotherapy and survival-limiting toxicity effects indicates …
MG Nix, CG Rowbottom, S Vivekanandan… - Radiotherapy and …, 2020 - Elsevier
Purpose To analyse changes in 2-year overall survival (OS 2yr) with radiotherapy (RT) dose,
dose-per-fraction, treatment duration and chemotherapy use, in data compiled from …
dose-per-fraction, treatment duration and chemotherapy use, in data compiled from …
[PDF][PDF] Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal …
T Piotrowski, M Matecka-Nowak, P Milecki - Neoplasma, 2005 - academia.edu
The purpose of the study was to determine the relation between the incidence of radiation
pneumonitis (RP) and available parameters from a dose-volume histogram (DVH) in …
pneumonitis (RP) and available parameters from a dose-volume histogram (DVH) in …
Comparison of futility monitoring guidelines using completed phase III oncology trials
Background: Futility (inefficacy) interim monitoring is an important component in the conduct
of phase III clinical trials, especially in life-threatening diseases. Desirable futility monitoring …
of phase III clinical trials, especially in life-threatening diseases. Desirable futility monitoring …
Undertreatment of elderly patients with non–small-cell lung cancer
R Ng, R de Boer, MD Green - Clinical lung cancer, 2005 - Elsevier
The absolute number of patients with lung cancer is rising as a result of our aging
population. Until recently, clinicians have been reluctant to aggressively treat elderly …
population. Until recently, clinicians have been reluctant to aggressively treat elderly …
Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy
NP Nguyen, M Bishop, TJ Borok, J Welsh… - Anticancer …, 2010 - ar.iiarjournals.org
Standard of care for locally advanced non-small cell lung cancer has been concurrent
chemoradiation. However, optimal chemotherapy regimen, radiation therapy dose and …
chemoradiation. However, optimal chemotherapy regimen, radiation therapy dose and …
Anastomosis Complications after Bronchoplasty: Incidence, Risk Factors, and Treatment Options Reported by a Referral Cancer Center
L Girelli, L Bertolaccini, M Casiraghi, F Petrella… - Current …, 2023 - mdpi.com
Background: Sleeve lobectomy with bronchoplasty is a safe surgical technique for the
management of lung cancer and endobronchial localization of extrapulmonary cancers …
management of lung cancer and endobronchial localization of extrapulmonary cancers …
Chemoradiotherapy for lung cancer
Y Ohe - Expert Opinion on Pharmacotherapy, 2005 - Taylor & Francis
Chemoradiotherapy is a standard treatment for both unresectable locally advanced non-
small cell lung cancer and limited-stage small cell lung cancer. Cisplatin-based …
small cell lung cancer and limited-stage small cell lung cancer. Cisplatin-based …
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
RM Huber, M Reck, M Thomas - European Respiratory Journal, 2013 - Eur Respiratory Soc
Stage III nonsmall cell lung cancer (NSCLC) encompasses a heterogeneous group of
patients, some of whom may be candidates for potentially curative surgery, although for the …
patients, some of whom may be candidates for potentially curative surgery, although for the …
New strategies in non–small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease
R Rengan, AM Maity, JP Stevenson, SM Hahn - Clinical cancer research, 2011 - AACR
The past decade has seen significant breakthroughs in our knowledge of the tumor biology
of non–small cell lung cancer (NSCLC). Signaling pathways that are vital for tumor growth …
of non–small cell lung cancer (NSCLC). Signaling pathways that are vital for tumor growth …